Published Sep 20, 2021

Dr. Matthew Johnson: Psychedelics for Treating Mental Disorders | Huberman Lab Podcast #38

Dr. Matthew Johnson delves into the transformative power of psychedelics for treating mental disorders, examining their neurochemical impact, cultural and legal shifts, and the therapeutic settings crucial for efficacy and safety. Amidst growing societal acceptance, Andrew Huberman and Dr. Johnson discuss potential benefits and the complexities of managing risks associated with these profound substances.
Episode Highlights
Huberman Lab logo

Popular Clips

Episode Highlights

  • Neurotransmitter Interaction

    Psychedelics primarily target the serotonin system, profoundly altering perception and consciousness. explains that compounds like LSD and psilocybin act as agonists at the serotonin 2A receptor, influencing behavioral and subjective effects 1. While serotonin generally promotes contentment, dopamine drives external focus and action, creating distinct experiences when influenced by psychedelics 2.

    The psychedelic space is an enormous cloud of partially overlapping compounds, impacting serotonin and dopamine systems differently.

    ---

    This interaction highlights the complexity of these substances and their potential therapeutic applications.

       

    Perceptual Shifts

    Psychedelics can dramatically alter perceptions of space, time, and self, leading to unique therapeutic effects. notes that these substances can cause synesthesia, where senses blend, and alter one's sense of reality by impacting the brain's space-time analysis 3. These experiences, though varied, often result in a better relationship with oneself and the world 4.

    The mind's eye can be on rocket boosters, expanding perceptions in profound ways.

    ---

    Such perceptual changes are central to the therapeutic potential of psychedelics, offering insights into depression and other mental health issues.

Related Episodes